Objective: To probe into the diagnosis and treatment of autoimmune hemolytic anemia (AIHA) induced by cefdinil dispersible tablets. Methods: The diagnosis and treatment of one child with AIHA induced by cefdinil dispersible tablets were analyzed. Combined with literature retrieval

the mechanism and countermeasures of AIHA induced by cefdinil dispersible tablets were explored. Results: After one day of oral administration of cefdinir dispersible tablets

AIHA occurred in the child. Cefdinir dispersible tablets was stopped immediately. Mepredronate sodium for injection was given to suppress the immune response

5% sodium bicarbonate alkalization of urine

oxygen inhalation and other symptomatic treatments were given

and hemolysis was controlled after drug withdrawal of one week. Conclusion: When cefdeni is used clinically in children

it is necessary to pay close attention to whether the child has clinical manifestations of hemolysis

so as to timely find out the problems and take appropriate treatment measures to ensure the safe medication